Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Chronic Inflammation in Modulating Targeted Therapy Efficacy and Predicting Treatment Outcomes in Metastatic Colorectal Cancer

NCT07241403 is registered in ClinicalTrials.gov with Second Affiliated Hospital of Nanchang University as lead sponsor.

NCT NCT07241403
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07241403 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Chronic Inflammation in Modulating Targeted Therapy Efficacy and Predicting Treatment Outcomes in Metastatic Colorectal Cancer
Lead sponsor
Second Affiliated Hospital of Nanchang University
Phase
Observational
Overall status
Completed
Start date
January 1, 2018
Completion date
April 21, 2025
Enrollment
698 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bevacizimab, colorectal cancer, inflamation, resistance